Literature DB >> 21076612

GATA6 promotes colon cancer cell invasion by regulating urokinase plasminogen activator gene expression.

Narasimhaswamy S Belaguli1, Muhammad Aftab, Mohammed Rigi, Mao Zhang, Daniel Albo, David H Berger.   

Abstract

GATA6 is a zinc finger transcription factor expressed in the colorectal epithelium. We have examined the expression of GATA6 in colon cancers and investigated the mechanisms by which GATA6 regulates colon cancer cell invasion. GATA6 was overexpressed in colorectal polyps and primary and metastatic tumors. GATA6 was strongly expressed in both the nuclear and cytoplasmic compartments of the colon cancer cells. GATA6 expression was upregulated in invasive HT29 and KM12L4 cells compared with the parental HT29 and KM12 cells and positively correlated with urokinase-type plasminogen activator (uPA) gene expression. Small interfering RNA (siRNA) knockdown of GATA6 resulted in reduced uPA gene expression and cell invasion. GATA6 bound to the uPA gene regulatory sequences in vivo and activated uPA promoter activity in vitro. uPA promoter deletion analysis indicated that the promoter proximal Sp1 sites were required for GATA6 activation of the uPA promoter. Accordingly, GATA6 physically associated with Sp1 and siRNA knockdown of Sp1 decreased GATA6 activation of the uPA promoter activity suggesting that Sp1 recruits GATA6 to the uPA promoter and mediates GATA6 induced activation of the uPA promoter activity. On the basis of our results, we conclude that GATA6 is an important regulator of uPA gene expression, and the dysregulated expression of GATA6 contributes to colorectal tumorigenesis and tumor invasion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21076612      PMCID: PMC2978909          DOI: 10.1593/neo.10224

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  58 in total

1.  Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.

Authors:  Erik T Kimchi; Mitchell C Posner; James O Park; Thomas E Darga; Masha Kocherginsky; Theodore Karrison; John Hart; Kerrington D Smith; James J Mezhir; Ralph R Weichselbaum; Nikolai N Khodarev
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

2.  Physical interaction between retinoic acid receptor and Sp1: mechanism for induction of urokinase by retinoic acid.

Authors:  Y Suzuki; J Shimada; K Shudo; M Matsumura; M P Crippa; S Kojima
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

3.  Reversal of GATA-6 downregulation promotes smooth muscle differentiation and inhibits intimal hyperplasia in balloon-injured rat carotid artery.

Authors:  T Mano; Z Luo; S L Malendowicz; T Evans; K Walsh
Journal:  Circ Res       Date:  1999-04-02       Impact factor: 17.367

4.  Cooperation between GATA4 and TGF-beta signaling regulates intestinal epithelial gene expression.

Authors:  Narasimhaswamy S Belaguli; Mao Zhang; Mohammed Rigi; Muhammad Aftab; David H Berger
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-02-08       Impact factor: 4.052

5.  A RUNX/AML-binding motif residing in a novel 13-bp DNA palindrome may determine the expression of the proximal promoter of the human uPA gene.

Authors:  E Kopf; R Miskin
Journal:  J Thromb Haemost       Date:  2005-09       Impact factor: 5.824

6.  Conserved POU/OCT- and GATA-binding sites in 5'-flanking promoter region of mammalian WNT8B orthologs.

Authors:  Masuko Katoh; Masaru Katoh
Journal:  Int J Oncol       Date:  2007-05       Impact factor: 5.650

7.  GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model.

Authors:  Deepak Kamnasaran; Baoping Qian; Cynthia Hawkins; William L Stanford; Abhijit Guha
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

8.  Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.

Authors:  M M Skelly; A Troy; M J Duffy; H E Mulcahy; C Duggan; T G Connell; D P O'Donoghue; K Sheahan
Journal:  Clin Cancer Res       Date:  1997-10       Impact factor: 12.531

9.  Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa.

Authors:  Hanna Haveri; Mia Westerholm-Ormio; Katri Lindfors; Markku Mäki; Erkki Savilahti; Leif C Andersson; Markku Heikinheimo
Journal:  BMC Gastroenterol       Date:  2008-04-11       Impact factor: 3.067

10.  Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer.

Authors:  Kevin A Kwei; Murali D Bashyam; Jessica Kao; Raman Ratheesh; Edumakanti C Reddy; Young H Kim; Kelli Montgomery; Craig P Giacomini; Yoon-La Choi; Sreejata Chatterjee; Collins A Karikari; Keyan Salari; Pei Wang; Tina Hernandez-Boussard; Gowrishankar Swarnalata; Matt van de Rijn; Anirban Maitra; Jonathan R Pollack
Journal:  PLoS Genet       Date:  2008-05-23       Impact factor: 5.917

View more
  33 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  Control of alveolar differentiation by the lineage transcription factors GATA6 and HOPX inhibits lung adenocarcinoma metastasis.

Authors:  William K C Cheung; Minghui Zhao; Zongzhi Liu; Laura E Stevens; Paul D Cao; Justin E Fang; Thomas F Westbrook; Don X Nguyen
Journal:  Cancer Cell       Date:  2013-05-23       Impact factor: 31.743

3.  GATA6 is required for proliferation, migration, secretory cell maturation, and gene expression in the mature mouse colon.

Authors:  Eva Beuling; Boaz E Aronson; Luc M D Tran; Kelly A Stapleton; Ellis N ter Horst; Laurens A T M Vissers; Michael P Verzi; Stephen D Krasinski
Journal:  Mol Cell Biol       Date:  2012-06-25       Impact factor: 4.272

Review 4.  Lineage factors and differentiation states in lung cancer progression.

Authors:  W K C Cheung; D X Nguyen
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

5.  Dinosaurs and ancient civilizations: reflections on the treatment of cancer.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

6.  MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6.

Authors:  Feng Xue; Jiwei Yin; Lin Xu; Boqing Wang
Journal:  Exp Ther Med       Date:  2017-04-18       Impact factor: 2.447

7.  Radiation-induced hypomethylation triggers urokinase plasminogen activator transcription in meningioma cells.

Authors:  Kiran Kumar Velpula; Venkateswara Rao Gogineni; Arun Kumar Nalla; Dzung H Dinh; Jasti S Rao
Journal:  Neoplasia       Date:  2013-02       Impact factor: 5.715

8.  Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells.

Authors:  Lei Sun; Lesley A Mathews; Stephanie M Cabarcas; Xiaohu Zhang; Acong Yang; Ying Zhang; Matthew R Young; Kimberly D Klarmann; Jonathan R Keller; William L Farrar
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

9.  Loss of fragile histidine triad and amplification of 1p36.22 and 11p15.5 in primary gastric adenocarcinomas.

Authors:  Yuan-Yuan Liu; Hai-Ying Chen; Man-Li Zhang; Dan Tian; Shibo Li; Ji-Yun Lee
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

10.  Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.